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The release of superoxide (02-) by polymorphonuclear leukocytes (PMN) is an important
function that contributes to microbial death. Controversy exists as to the effect of bacterial
endotoxin (lipopolysaccharide, or LPS) on the production of 02-- We have injected rabbits with
25 jAg Escherichia coli LPS intravenously and studied PMN function 18 to 24 hours later.
Relative to PMN from saline-injected controls, PMN from LPS-treated rabbits released
markedly greater amounts of 02- in response to 10 ng/ml phorbol myristate acetate (PMA) as
measured by nmol cytochrome C reduced in 20 minutes (40.8 ± 7.8 for LPS-treated PMN versus
10.1 ± 1.6 for control, p < 0.01). LPS injection, however, significantly reduced 02- release in
response to C (complement) 5a (1.4 ± 0.6 nmole/20 minutes for LPS-treated PMN versus 5.6 +
1.3 nmole/20 minutes for control, p < 0.01). 2- release in response to a third stimulus,
n-formyl-methionyl-leucyl-phenylalanine (10-7 to 10-9 M), was not affected by LPS. 02- release
in response to PMA was enhanced over a wide range of PMA concentrations (10 to 300 ng/ml).
Kineticstudies over 30 minutes indicated that, after a briefinitial latency in measurable response,
LPS enhanced responsiveness to PMA at all time points observed. The reduced responsiveness to
C5a corresponds to a previously reported down regulation of receptors for this ligand after
intravenous LPS. The observations indicate that intravenous LPS can alter a critical function of
PMN for at least 24 hours in a stimulus-specific manner.
INTRODUCTION
Studies on the effect of endotoxin (bacterial lipopolysaccharide, or LPS) on the
production of superoxide by polymorphonuclear leukocytes (PMN) have yielded
conflicting results. Guthrie and colleagues [1], for example, have reported that the
exposure of human PMN to endotoxin in vitro enhances their capability to release
superoxide in response to immune complexes, phorbol myristate acetate (PMA), or
n-formyl-methionyl-leucyl-phenylalanine (FMLP). In contrast, Proctor [2] found that
prior exposure ofhuman PMN to LPS reduced their ability to release 2- in response
to bacterial stimuli. Henricks and colleagues [3] used 18-hour incubations of PMN
and LPS to characterize the effects of endotoxin on O2- release. These investigators
found that LPS from Escherichia coli 01 1 1B4 and from the polysaccharide-deficient
mutant J5 enhanced O2- production when LPS itself was used as a stimulus. Using
staphylococcus as a stimulus, however, LPS 01 1 1B4 enhanced O2- release, while the
LPS from J5 reduced it.
We have recently characterized the effects of intravenously injected endotoxin on
PMN function in a rabbit model. We have previously reported that intravenously
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injected endotoxin (1) inhibits the vascular permeability and PMN extravasation from
blood vessels that is associated with a dermal reversed passive Arthus reaction [4]; (2)
inhibits chemotaxis and degranulation in response to C (complement) 5a but not in
response to FMLP [4,5]; and (3) down regulates the receptor for C5a while causing a
marked increase in the number ofreceptors for FMLP [6].
Superoxide production plays an integral part in microbial killing by PMN and also
contributes to inflammation. We have assessed the effects of intravenously injected
endotoxin on the ability ofrabbit PMN to release 02-
METHODS
Animals
Two-kilogram New Zealand White female rabbits were purchased from Animals
West (Soquel, CA). They were housed in the animal care facilities of the Medical
Research Institute ofSan Francisco and fed standard laboratory chow.
Isolation ofPMN
Rabbit PMN were isolated from acid-citrate-dextrose anticoagulated blood
obtained from the central ear artery, as we have previously described [4]. Thirty-four
ml of blood plus 6 to 8 ml of anticoagulant were mixed with 8 ml of 6 percent
(weight/volume) Dextran T500 (Pharmacia Fine Chemicals, Piscataway, NJ) in
normal saline. After sedimenting for approximately 30 minutes, the supernatant was
layered over 56 percent Percoll (Sigma Chemical Co., St. Louis, MO) and centrifuged
at 450 g for 20 minutes. The erythrocyte/PMN pellet from this centrifugation was
suspended for seven minutes in 40 ml of 8.3 percent (weight/volume) ammonium
chloride (pH 7.2) to produce lysis oferythrocytes. The pellet ofPMN was then washed
twice with phosphate buffered saline (300 mM, pH = 7.2) (GIBCO, Grand Island,
New York).
Endotoxin
E. coli LPS 055:B5 was purchased from RIBI Immunochem (Hamilton, MT). It
was suspended in saline prior to use and stored at -200C. Control rabbits received
sterile, pyrogen-free saline in volume comparable to that used for endotoxin injection.
Superoxide Release Assay
Rabbit PMN were suspended in a buffer ofHanks' balanced salt solution (GIBCO)
plus 0.25 percent bovine serum albumin (Sigma Chemicals, St. Louis, MO) at a
concentration of 5 x 106/ml. Stimuli in variable concentrations were added to the
reaction mixture that included PMN and ferricytochrome C (Sigma) (0.08 mM in
phosphate buffered saline, final concentration). The reaction was stopped after 20
minutes by placing the cells on ice for five minutes. Cells were removed by
centrifugation at 2,000 rpm for five minutes and the reduction of ferricytochrome C
was judged by the change in absorption at 550 nm [7]. The reduction of ferricyto-
chrome C could be inhibited by including superoxide dismutase (Sigma) (20 ng/ml) in
the reaction mixture. Data are expressed as the reduction of ferricytochrome C in
response to stimulus minus the reduction in control reaction mixtures incubated in
buffer alone. To control for day-to-day assay variability, each assay included PMN
from one saline-injected rabbit and one endotoxin-injected rabbit. For kinetics
experiments, cells were maintained at 370C in a Perkin-Elmer spectrophotometer with
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TABLE 1
The Effect of Intravenous LPS on PMN Superoxide Reduction
Source ofPMN
Stimulus LPS-Injected Saline-Injected
C5a (1 percent) (n = 8) 1.4 ± 0.6 5.6 ± 1.3
PMA (10 ng/ml) (n = 9) 40.8 ± 7.8 10.1 ± 1.6
FMLP (10-'M) (n = 6) 8.2 ± 3.3 9.7 ± 1.6
Data expressed as nmol cytochrome C reduced/20 minutes
continuous stirring. Absorbance readings were made once per minute. Rabbit C5a was
partially purified from zymosan (ICN Biochemicals, Cleveland, OH) activated rabbit
serum through a combination ofsizing and ion exchange column chromatography, as
we have previously described [4]. The concentration used for superoxide release was 1
percent, roughly twofold greater than the optimal concentration for chemotaxis [5].
PMA was purchased from Sigma. FMLP was purchased from Peninsula Laboratories
(San Carlos, CA), dissolved in dimethyl sulfoxide, and stored frozen at -200C.
Statistics
Data are expressed as mean ± SE and compared by the student's t-test.
RESULTS
Rabbits received 25 ,ug of LPS intravenously or a comparable volume ofsaline and
were bled 18 to 24 hours later. As shown in Table 1, PMN from LPS-treated rabbits
released significantly less 02- in response to 1 percent C5a than PMN from
saline-injected controls (p < 0.01). In marked contrast, PMN from LPS-treated
rabbits released fourfold more 02 in response to PMA (10 ng/ml) than PMN from
control rabbits (p < 0.01). Both sets ofPMN released 2- comparably in response to
FMLP (10-7 M). The unstimulated release of 02- was also comparable for the two
groups (7.2 ± 1.4nmol/20 minutes vs. 8.0 ± 1.8 nmol/20 minutes saline-treated versus
LPS-treated PMN, respectively). Superoxide release was also studied at two lower
concentrations of FMLP, 10-8 and 10-0 M. For three pairs of rabbit PMN at each
concentration, there was no statistical difference in 2- release (data not shown).
Theincreased capacity torelease 2- was evident atconcentrations ofPMA ranging
from 10 to 300 ng/ml (Fig. 1). Increasing the PMA concentration from 100 to 300
ng/ml appeared to induce minimal additional release of 02-, suggesting that PMN
had reached a plateau in responsiveness to PMA at a similar concentration, regardless
ofthe prior in vivo exposure to endotoxin (Fig. 1). In the studies summarized in Fig. 1,
PMN from saline-treated rabbits were more responsive to PMA (10 ng/ml) than the
control PMN, whose responses are noted in Table 1. This discrepancy reflects thedaily
variability ofthe assay. To control this variability, paired observations were made such
that PMN from oneendotoxin-injected rabbit and onesaline-injected rabbit were each
tested in the same day's assay.
As shown in Fig. 2, after a short initial latency in responsiveness, superoxide
production appeared to be linear for PMN obtained after either an LPS or saline
injection. The rate of production or slope differs in the two curves, but the linearity of
the response is preserved.
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ENDOTOXIN ENHANCES O- PRODUCTION IN RESPONSE
TO PMA OVER A WIDE RANGE OF CONCENTRATIONS
X
100
Concentration of PMA (ng/mI)
N.
- PMN from endotoxin-injected rabbits
"// PMN from saline-injected rabbits
FIG 1. PMN from endotoxin-
/ injected rabbits released greater
amounts of superoxide at each concen-
100 tration of PMA tested. For both PMN
from endotoxin-injected rabbits and
4 from saline-injected controls, increas-
ing PMA from 100 to 300 ng/ml
induced only a minimal increment in
superoxide release.
DISCUSSION
We have previously demonstrated that intravenously injected LPS results in
stimulus-specific changes in rabbit PMN [4-6]. Stimulus-specific changes have been
characterized relative to receptor number and functional alterations in chemotaxis and
degranulation [4-6]. Recently in clinical studies stimulus-specific changes in PMN
function, including a depressed chemotactic response to C5a, have been noted in such
diverse disorders as burns and inflammatory skin disease [8,9]. The present study
extends our previous observations by considering the effect ofintravenous LPS on the
ability ofPMN to generate superoxide in response to soluble stimuli.
Similar to the observations of Guthrie and colleagues [1], we find that LPS can
markedly enhance the release of 02- by PMN. Our observations, however, are in
contrast to previous studies in that we have studied a system that involves in vivo
exposure to LPS, and we find that the enhancement of 02- production is highly
stimulus-specific. Using PMA as a stimulus, intravenous LPS appears to enhance 2-
release independent of the dose of PMA or of the time point studied. In contrast,
intravenous LPS reduced responsiveness to C5a and did not alter responsiveness to
394
90-
85
so
80
75
70-
65-
60-
E 55-
a C,' so * 50-
45.
a 40-
46
30-
25
20-
15
10
5.
0-
3EFFECT OF ENDOTOXIN ON SUPEROXIDE PRODUCTION
100 - THE RATE OF °2 RELEASE
X -.-* PMN from LPS treated rabbits
0
o 75-vo PMN from saline treated rabbits Z
50 o / FIG. 2. PMN from
., wf LPS-treated rabbits and
O ,/ from controls both released
25 - superoxide in an apparently 0 E -0 _O O linear fashion after an initial
- / _ _ lag period; 10 ng/ml PMA
was used as a stimulus. Data
0, 0 5 10 15 20 25 30 are from asingle experiment
Minutes representative ofthree.
FMLP. The reduced response to C5a withoutcomparablechange in response to FMLP
is also seen for chemotaxis, degranulation, and dermal vascular permeability [4,5].
A number of mechanisms might contribute to these observations. Direct binding of
LPS, synthesis of soluble factors such as tumor necrosis factor, down regulation of
receptors for the chemotactic ligand caused by the generation ofchemotactic factors,
and demargination of subpopulations of PMN could each contribute to the effects of
LPS on PMN, as we havepreviously noted [4,5]. Thealteration ofPMN function after
in vivo exposure to LPS supports the likelihood that this effect is physiologic. It may
account in part for the enhanced oxidative metabolism (as measured bychemilumines-
cence, 02- release, or nitro-blue tetrazolium reduction) that has been noted in
association with bacterial infection by some investigators [10-12].
Since intravenous LPS down regulates the receptor for C5a [6], the LPS-induced
reduction in 2- release in response to this ligand may at least in part reflect a
receptor-determined change. Since intravenous LPS markedly increases the numberof
receptors for FMLP [6] without enhancing 2- release in response to that stimulus,
however, it appears that additional subsequent post-receptor events must be rate-
limiting. Furthermore, since 2- release in response to PMA is enhanced by intrave-
nous LPS, the post-receptor regulation ofsuperoxide release may differ for PMA and
FMLP. Other investigators have reported that discrepant intracellular events appear
to determine PMN responses to chemotactic ligands, as opposed to responses to PMA.
Pertussis toxin, for example, an inhibitor of the guanosine triphosphate binding
protein, Ni, inhibits granule release in response to C5a and FMLP, but not in response
to PMA [13]. Inguinea pig PMN, FMLPinduces the breakdown ofphosphatidylinosi-
tol 4,5 biphosphate and the subsequent formation ofdiacylglycerol, phosphatidic acid,
and free arachidonic acid. PMA fails to induce the breakdown ofphosphatidylinositol
4,5 biphosphate or the release of arachidonate [14]. A recent study indicates that a
phagocytosable stimulus induces 2- release through a different pathway, in compari-
son to PMA [15]. Different intracellular pathways or differential activation of
regulatory substances that control the same metabolic pathway could conceivably
account for discordant effects on 2- release in response to different stimuli. This
hypothesis could account for the ability of LPS to enhance or suppress 2- release,
depending upon the stimulus studied.
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